Novartis Nabs Former Siemens CCO

Klaus Moosmayer will join the Swiss pharmaceutical company as chief ethics, risk and compliance officer and a member of the executive committee in December. For more on Novartis, see “Remediating Corruption Issues Uncovered During Third-Party Audits” (Oct. 4, 2017).

To read the full article

Continue reading your article with an ACR subscription.